Shoji Kudoh

738 total citations
20 papers, 536 citations indexed

About

Shoji Kudoh is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Infectious Diseases. According to data from OpenAlex, Shoji Kudoh has authored 20 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Infectious Diseases. Recurrent topics in Shoji Kudoh's work include Tuberculosis Research and Epidemiology (4 papers), Respiratory viral infections research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Shoji Kudoh is often cited by papers focused on Tuberculosis Research and Epidemiology (4 papers), Respiratory viral infections research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). Shoji Kudoh collaborates with scholars based in Japan and United Kingdom. Shoji Kudoh's co-authors include Arata Azuma, Jiro Usuki, Masaru Oritsu, Shinya Abe, T. Nukiwa, K Sugisaki, Isao Yoshimura, Akira Watanabe, Seizaburo Kashiwagi and A. Watanabe and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Lung Cancer.

In The Last Decade

Shoji Kudoh

19 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shoji Kudoh Japan	8	326	306	191	68	40	20	536
Hidekazu Matsushima Japan	14	342 1.0×	110 0.4×	137 0.7×	25 0.4×	92 2.3×	78	507
Kazuki Konishi Japan	7	248 0.8×	167 0.5×	45 0.2×	25 0.4×	21 0.5×	25	380
T. G. Villar Portugal	7	195 0.6×	216 0.7×	57 0.3×	33 0.5×	52 1.3×	14	372
G. Anderson United Kingdom	9	248 0.8×	134 0.4×	99 0.5×	26 0.4×	21 0.5×	19	387
G Paone Italy	11	212 0.7×	69 0.2×	112 0.6×	53 0.8×	44 1.1×	24	427
D Müller-Wening Germany	9	233 0.7×	77 0.3×	47 0.2×	30 0.4×	45 1.1×	24	397
Anna Stainer Italy	12	279 0.9×	80 0.3×	140 0.7×	45 0.7×	30 0.8×	37	429
Byoung Soo Kwon South Korea	13	243 0.7×	73 0.2×	205 1.1×	28 0.4×	64 1.6×	47	500
Ann Decraene Belgium	8	254 0.8×	145 0.5×	53 0.3×	27 0.4×	59 1.5×	13	412
Susheel Kumar India	11	110 0.3×	45 0.1×	115 0.6×	48 0.7×	71 1.8×	41	381

Countries citing papers authored by Shoji Kudoh

Since Specialization

Citations

This map shows the geographic impact of Shoji Kudoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Kudoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Kudoh more than expected).

Fields of papers citing papers by Shoji Kudoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoji Kudoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Kudoh. The network helps show where Shoji Kudoh may publish in the future.

Co-authorship network of co-authors of Shoji Kudoh

This figure shows the co-authorship network connecting the top 25 collaborators of Shoji Kudoh. A scholar is included among the top collaborators of Shoji Kudoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoji Kudoh. Shoji Kudoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osawa, Takeshi, Masato Watanabe, Kozo Morimoto, et al.. (2023). Activities of Daily Living, Hypoxemia, and Lymphocytes Score for Predicting Mortality Risk in Patients With Pulmonary TB. CHEST Journal. 165(2). 267–277. 4 indexed citations

Sasaki, Yuka, Atsuyuki Kurashima, Kozo Morimoto, et al.. (2014). [Experience of rapid drug desensitization therapy in the treatment of mycobacterial disease].. PubMed. 89(11). 797–802. 3 indexed citations

Okumura, Masao, Takashi Yoshiyama, Hideo Ogata, et al.. (2011). [Factors related to the occurrence of multi- (extensively-) drug resistant tuberculosis (M/XDR-TB) in our hospital].. PubMed. 86(11). 863–8.

Nei, Takahito, et al.. (2007). Microbial substitution of Mycobacterium avium-intracellulare to Mycobacterium abscessus during clinical course. Journal of Infection and Chemotherapy. 13(5). 343–345. 3 indexed citations

Azuma, Arata, Shinya Abe, Jiro Usuki, et al.. (2007). Epidemiology of sarcoidosis in Japan. European Respiratory Journal. 31(2). 372–379. 280 indexed citations

Azuma, Arata, et al.. (2003). Familial clustering of dendriform pulmonary ossification.. PubMed. 20(2). 152–4. 25 indexed citations

Matsumoto, Keizō, Shoji Kudoh, Norio Sugaya, & Hiroshi Suzuki. (2002). Patient Assessment for Zanamivir Therapy (Second report). Kansenshogaku zasshi. 76(12). 1016–1024. 1 indexed citations

Enomoto, Tatsuji, Masashi Kawamoto, Shinobu Kunugi, et al.. (2002). [Clinicopathological analysis of patients with idiopathic pulmonary fibrosis which became acutely exacerbated after video-assisted thoracoscopic surgical lung biopsy].. PubMed. 40(10). 806–11. 7 indexed citations

Matsumoto, Kinzo, Shoji Kudoh, Norio Sugaya, & Hiroaki Suzuki. (2001). Patient Assessment for Zanamivir Therapy. Kansenshogaku zasshi. 75(9). 800–807. 1 indexed citations

10.

Kashiwagi, Seizaburo, Shoji Kudoh, Akira Watanabe, & Isao Yoshimura. (2000). Clinical Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza. Kansenshogaku zasshi. 74(12). 1044–1061. 36 indexed citations

11.

Kashiwagi, S, Shoji Kudoh, A. Watanabe, & Isao Yoshimura. (2000). Efficacy and Safety of the Selective Oral Neuraminidase Inhibitor Oseltamivir for Prophylaxis against Influenza. Kansenshogaku zasshi. 74(12). 1062–1076. 28 indexed citations

12.

Tamura, Takeshi, et al.. (2000). A Phase I intermittent dose-escalation trial of ZD1839 (IressaTM) in Japanese patients with solid malignant tumors. Lung Cancer. 29(1). 71–71. 15 indexed citations

13.

Matsumoto, Kinzo, Noriyoshi Ogawa, K. Nerome, et al.. (1999). Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.. PubMed. 4(2). 61–8. 40 indexed citations

14.

Omata, Masako, Mitsunori Hino, Yoshiharu Ohaki, et al.. (1999). Mediastinal yolk sac tumor in a woman. International Journal of Clinical Oncology. 4(4). 248–252. 2 indexed citations

15.

Kudoh, Shoji. (1998). Erythromycin treatment in diffuse panbronchiolitis. Current Opinion in Pulmonary Medicine. 4(2). 116–116. 74 indexed citations

16.

Nitta, Takashi, M. Fukuoka, Y Kusunoki, et al.. (1995). Significance of Serum Neuron-specific Enolase as a Predictor of Relapse of Small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 25(5). 179–83. 5 indexed citations

17.

Shimada, Kaoru, Shoji Kudoh, Hiroaki Shishido, et al.. (1994). [Clinical usefulness of the combined empirical therapy with flomoxef and fosfomycin for intractable respiratory tract infections. With a background of increasing MRSA incidence].. PubMed. 47(10). 1299–304. 1 indexed citations

18.

Ieki, Ryuji, Shoji Kudoh, Hideo Kimura, et al.. (1990). Human granulocyte colony formation in serum-free cultures stimulated with purified recombinant granulocyte colony-stimulating factor.. PubMed. 18(8). 883–7. 4 indexed citations

19.

Watanabe, Hiroshi, et al.. (1985). Metastases to the Rouviere Nodes and Headache. Auris Nasus Larynx. 12(1). 53–56. 6 indexed citations

20.

Kudoh, Shoji, Kenji Sasaki, Hideki Yotsumoto, et al.. (1978). [Clinical significance of bronchiolar lesions in sinobronchial syndrome and its etiological study].. PubMed. 36(6). 2484–95. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact